ZEB1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
Simone Meidhof(University of Freiburg), Thomas Brabletz(German Cancer Research Center)
Cited by 230
Related Papers
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
|Nature Cell Biology|2017|976
β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer
|American Journal Of Pathology|1999|663
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
|Nature Communications|2016|296